Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Corcept Therapeutics	Rocket Pharmaceuticals	Deciphera Pharmaceuticals	Amicus Therapeutics	Organogenesis
Symbol	NASDAQ:CORT	NASDAQ:RCKT	NASDAQ:DCPH	NASDAQ:FOLD	NASDAQ:ORGO
Price Information
Current Price	$21.10	$43.77	$34.33	$9.75	$21.15
52 Week Range	Buy	Buy	Buy	Hold	Buy
MarketRank™
Overall Score	1.8	1.4	1.8	1.6	1.0
Analysis Score	2.3	3.5	4.4	4.2	1.5
Community Score	2.7	2.9	2.5	3.0	2.6
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	1.7	0.8	1.7	0.0	0.8
Earnings & Valuation Score	2.5	0.0	0.6	0.6	0.0
Analyst Ratings
Consensus Recommendation	Buy	Buy	Buy	Hold	Buy
Consensus Price Target	$24.00	$59.18	$73.00	$20.04	$16.50
% Upside from Price Target	13.74% upside	35.21% upside	112.64% upside	105.52% upside	-21.99% downside
Trade Information
Market Cap	$2.46 billion	$2.70 billion	$1.99 billion	$2.59 billion	$2.71 billion
Beta	1.04	2.05	1.49	1.57	1.84
Average Volume	554,552	482,502	453,821	3,716,117	824,795
Sales & Book Value
Annual Revenue	$306.49 million	N/A	$25 million	$182.24 million	$260.98 million
Price / Sales	8.03	N/A	79.60	14.23	10.39
Cashflow	$0.63 per share	N/A	N/A	N/A	N/A
Price / Cash	33.26	N/A	N/A	N/A	N/A
Book Value	$3.25 per share	$6.10 per share	$10.71 per share	$1.87 per share	$0.59 per share
Price / Book	6.49	N/A	3.21	5.21	35.85
Profitability
Net Income	$94.18 million	$-77,270,000.00	$-192,260,000.00	$-356,390,000.00	$-40,450,000.00
EPS	$0.77	($1.58)	($4.48)	($1.31)	($0.42)
Trailing P/E Ratio	23.71	N/A	N/A	N/A	N/A
Forward P/E Ratio	22.93	N/A	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	30.73%	N/A	N/A	-120.18%	-1.61%
Return on Equity (ROE)	25.38%	-35.81%	-45.02%	-73.81%	-10.03%
Return on Assets (ROA)	23.16%	-27.52%	-40.12%	-36.10%	-2.22%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	0.25%	N/A	1.21%	1.54%
Current Ratio	10.77%	7.30%	9.34%	5.24%	1.95%
Quick Ratio	10.65%	7.30%	9.26%	5.10%	1.50%
Ownership Information
Institutional Ownership Percentage	75.44%	N/A	73.61%	N/A	4.62%
Insider Ownership Percentage	16.40%	41.40%	7.02%	2.50%	57.20%
Miscellaneous
Employees	236	91	350	483	910
Shares Outstanding	116.63 million	61.78 million	57.96 million	266.03 million	128.21 million
Next Earnings Date	8/3/2021 (Estimated)	5/12/2021 (Estimated)	8/3/2021 (Estimated)	5/10/2021 (Confirmed)	5/10/2021 (Confirmed)
Optionable	Optionable	Optionable	Optionable	Optionable	Not Optionable

Source	Headline
	Organogenesis Showcases Latest Advanced Wound Care - GlobeNewswire globenewswire.com - May 8 at 8:50 AM
	Zacks Investment Research Lowers Organogenesis (NASDAQ:ORGO) to Hold marketbeat.com - May 8 at 2:26 AM
	Earnings Outlook for Organogenesis Holdings - Benzinga benzinga.com - May 7 at 1:02 PM
	Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Spring \| WHS 2021 Virtual Meeting - Yahoo Finance finance.yahoo.com - May 6 at 10:01 PM
	Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Spring \| WHS 2021 Virtual Meeting finance.yahoo.com - May 6 at 10:01 PM
	05:00 ET 2020 STELLARIS Award Recipient Announced - PRNewswire prnewswire.com - May 6 at 7:00 AM
	Automotive Axle and Propeller Shaft Market 2026 Maximum Benefit and Growth Potential During this COVID 19 Outbreak \| 3M, Organogenesis, Smith & Nephew, ConvaTec Group, Coloplast – FLA News - FLA News flanewsonline.com - May 5 at 3:54 PM
	A Look At The Fair Value Of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Nasdaq nasdaq.com - May 5 at 3:54 PM
	Has Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Impressive Stock Performance Got Anything to Do With Its Fundamentals? - Yahoo Finance finance.yahoo.com - May 5 at 3:54 PM
	Has Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Impressive Stock Performance Got Anything to Do With Its Fundamentals? finance.yahoo.com - May 5 at 3:54 PM
	Wound Care Biologics Market Demand, Status and Global Briefing 2021 to 2025 \| Smith & Nephew, Osiris, Integra, Organogenesis, Amnio Technology – The Shotcaller - The Shotcaller theshotcaller.net - May 5 at 10:52 AM
	Is it Time to Dump Organogenesis Holdings Inc (ORGO) Stock After it Has Risen 0.09% in a Week? - InvestorsObserver investorsobserver.com - May 4 at 11:03 PM
	Organogenesis (NASDAQ:ORGO) Trading Down 7.4% americanbankingnews.com - May 4 at 1:14 PM
	COVID-19 Analysis on Advanced Wound Care Market Report for Q1- 2021 compared to 2020\|Expected to reach USD 3.15 billion by 2025\|Technavio - PRNewswire prnewswire.com - May 4 at 1:03 PM
	Amniotic Products Market Boosting the Growth Worldwide: iMedx, Smith & Nephew, Organogenesis – Clark County Blog - Clark County Blog clarkcountyblog.com - May 4 at 8:03 AM
	Organogenesis Holdings Inc. (NASDAQ:ORGO) Sees Large Increase in Short Interest americanbankingnews.com - May 3 at 4:42 PM
	Organogenesis (NASDAQ:ORGO) Shares Gap Up to $22.36 americanbankingnews.com - May 3 at 12:06 PM
	Amniotic Products Market SWOT Analysis, Business Growth Opportunities by Top Companies : MiMedx,Smith & Nephew,Organogenesis,Integra LifeSciences Corporation – Good News Gum - Good News Gum goodnewsgum.com - May 3 at 10:00 AM
	Premarket Mover: Organogenesis Holdings Inc (ORGO) Up 8.14% - InvestorsObserver investorsobserver.com - May 3 at 10:00 AM
	Skin Substitutes and Wound Care Market Global Analysis 2021-2028: Smith and Nephew, Medtronic (Covidien), Organogenesis, Inc, Scapa Healthcare, and Many More. – Clark County Blog - Clark County Blog clarkcountyblog.com - May 1 at 5:51 PM
	Organogenesis (NASDAQ:ORGO) Shares Up 4.6% americanbankingnews.com - April 30 at 11:39 AM
	Is Organogenesis Holdings Inc (ORGO) Stock a Smart Value Friday? - InvestorsObserver investorsobserver.com - April 30 at 10:32 AM
	Skin Graft Market 2021 Will Reflect Significant Growth in Future with Size, Share, Growth, and Key Companies Analysis- Organogenesis, Inc., Specmed Medical, Tissue Regenix Group PLC., Avita Medical, Convatec Inc., etc. - Clark County Blog clarkcountyblog.com - April 29 at 8:01 AM
	Global Skin Replacement and Substitute Market 2021 Analysis – Acelity LP Inc., MiMedx Group Inc., Organogenesis Inc. – Valley Bugler Newspaper - Valley Bugler Newspaper valleybugler.com - April 28 at 3:15 PM
	Label Heat Shrinkable Film Market : Growth Factors and Competitive Players till 2026\| Allergan, Integra Lifesciences, CR Bard, Zimmer Biomet, Organogenesis, Osiris Therapeutics – Clark County Blog - Clark County Blog clarkcountyblog.com - April 28 at 10:14 AM
	Global Amniotic Product Market 2021 Future Trends – MiMedx, Smith & Nephew, Organogenesis, Integra LifeSciences Corporation, Stryker Corporation, Wright Medical - Valley Bugler Newspaper valleybugler.com - April 28 at 10:14 AM
	Zacks Investment Research Downgrades Organogenesis (NASDAQ:ORGO) to Hold marketbeat.com - April 17 at 3:20 AM

Date	Company	Brokerage	Action
11/27/2020	Corcept Therapeutics	HC Wainwright	Boost Price Target
8/5/2020	Corcept Therapeutics	Jefferies Financial Group	Downgrade
2/21/2020	Corcept Therapeutics	Cantor Fitzgerald	Reiterated Rating
2/5/2019	Corcept Therapeutics	B. Riley	Set Price Target
8/10/2018	Corcept Therapeutics	Stifel Nicolaus	Reiterated Rating
4/1/2021	Rocket Pharmaceuticals	SVB Leerink	Boost Price Target
2/25/2021	Rocket Pharmaceuticals	Needham & Company LLC	Initiated Coverage
1/4/2021	Rocket Pharmaceuticals	Piper Sandler	Boost Price Target
12/15/2020	Rocket Pharmaceuticals	UBS Group	Initiated Coverage
12/10/2020	Rocket Pharmaceuticals	Evercore ISI	Boost Price Target
12/8/2020	Rocket Pharmaceuticals	Chardan Capital	Boost Price Target
12/8/2020	Rocket Pharmaceuticals	Oppenheimer	Downgrade
11/23/2020	Rocket Pharmaceuticals	JPMorgan Chase & Co.	Boost Price Target
10/16/2020	Rocket Pharmaceuticals	Lifesci Capital	Reiterated Rating
8/9/2020	Rocket Pharmaceuticals	Cowen	Reiterated Rating
8/5/2020	Rocket Pharmaceuticals	Ci Capital	Reiterated Rating
6/25/2020	Rocket Pharmaceuticals	Bank of America	Initiated Coverage
5/6/2020	Rocket Pharmaceuticals	William Blair	Reiterated Rating
5/5/2021	Deciphera Pharmaceuticals	Barclays	Lower Price Target
3/30/2021	Deciphera Pharmaceuticals	Credit Suisse Group	Initiated Coverage
6/12/2020	Deciphera Pharmaceuticals	Guggenheim	Reiterated Rating
5/18/2020	Deciphera Pharmaceuticals	SunTrust Banks	Boost Price Target
5/7/2020	Deciphera Pharmaceuticals	Nomura Instinet	Downgrade
1/21/2020	Deciphera Pharmaceuticals	Nomura Securities	Boost Price Target
1/15/2020	Deciphera Pharmaceuticals	JMP Securities	Reiterated Rating
3/3/2021	Amicus Therapeutics	Robert W. Baird	Reiterated Rating
2/12/2021	Amicus Therapeutics	Citigroup	Lower Price Target
12/10/2020	Amicus Therapeutics	Smith Barney Citigroup	Downgrade
12/10/2020	Amicus Therapeutics	Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell	Downgrade
11/11/2020	Amicus Therapeutics	Berenberg Bank	Initiated Coverage
6/16/2020	Amicus Therapeutics	BTIG Research	Initiated Coverage

(Data available from 5/8/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources